Risk Factors for the Occurrence of Rebound Pain After Intercostal Nerves Block in Three-Port Thoracoscopic Surgery: A Case-Control Study

三孔胸腔镜手术中肋间神经阻滞后反跳痛发生的危险因素:一项病例对照研究

阅读:1

Abstract

BACKGROUND AND OBJECTIVES: Rebound pain (RP), characterised by an acute increase in pain levels, is usually observed after the effects of block anaesthesia have subsided. Severe RP can cause adverse effects, thus affecting patient prognosis. In this study, we investigated the incidence of RP and its risk factors after intercostal nerve block in three-port thoracoscopic surgery to provide a clinical basis for identifying high-risk patients and providing early intervention. METHODS: A single-centre retrospective study was conducted on 475 patients who underwent three-hole thoracoscopic surgery from September 2022 to September 2023 in Jiaxing First Hospital. Data were collected and compared between patients who developed RP and those who did not. IBM SPSS Statistics 25.0 software was used for statistical analysis. RESULTS: Data were collected from 700 patients. After applying the exclusion criteria, 475 cases were finally included and the incidence of RP was 23.8%. The results showed that the differences in body mass index (BMI), upper and lower chest diameters, anterior and posterior chest diameters, left and right chest diameters, and gender between patients with RP and those without RP were statistically significant (p < 0.05). In addition, the proportion of female patients with RP was significantly higher. BMI (advantage ratio [OR] = 0.835, 95% confidence interval [CI]: 0.375 ~ 1.859), upper and lower chest diameters (OR = 0.916, 95% CI: 0.827 ~ 1.014), anterior and posterior chest diameters (OR = 0.765, 95% CI: 0.635 ~ 0.921), left and right chest diameters (OR = 0.612, 95% CI: 0.421 ~ 0.891), and gender (OR = 1.170, 95% CI: 0.576 ~ 2.373). CONCLUSION: The incidence of RP after three-hole thoracoscopic intercostal nerve block is high and associated with multiple risk factors. Early intervention is needed for patients at risk of RP to improve patient prognosis and satisfaction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。